首页 | 本学科首页   官方微博 | 高级检索  
检索        

长期雌激素替代治疗对血压及心肌IR和IRS-1表达的影响
引用本文:刘美莲,徐霞,谢平,卢瑾,陈淑华,曾卫民,宋惠萍.长期雌激素替代治疗对血压及心肌IR和IRS-1表达的影响[J].中南大学学报(医学版),2005,30(1):38-40.
作者姓名:刘美莲  徐霞  谢平  卢瑾  陈淑华  曾卫民  宋惠萍
作者单位:中南大学生物科学与技术学院生物化学系,长沙 410078
基金项目:国家自然科学基金(30300137),湖南省自然科学基金(01JJY017)
摘    要:目的:研究长期雌激素替代治疗对血压及心肌组织胰岛素受体(IR)和胰岛素受体底物-1(IRS-1)表达水平的影响。方法:将50只雌性SD大鼠随机分成3组,构建假手术、去势(去卵巢)和雌激素替代3组动物模型。手术前后,用尾套法测定大鼠的尾动脉收缩压,RT-PCR方法检测大鼠心肌IR和IRS-1的表达。结果:去势组血压[(118.75±2.77) mmHg]明显高于假手术组 [(103.86±1.84)mmHg,P<0.05]和替代组[(107.83±3.24)mmHg,P<0.05] 。去势组大鼠心肌IRS-1的相对表达量(1.2588±0.1045)显著低于假手术组(2.2089±0.0988, P<0.05)和替代组(1.9100±0.1230,P<0.05)。然而,替代组与假手术组间血压和IRS-1的表达无明显差异(P>0.05)。假手术、去卵巢和替代组间心肌IR的表达差异无统计学意义(P>0.05)。结论:长期雌激素替代治疗可降低血压、增加心肌细胞IRS-1的表达,从而一定程度上保护心血管。但血清雌激素水平对心肌细胞IR的表达影响不明显。

关 键 词:雌激素替代治疗  血压  胰岛素敏感性  胰岛素受体  胰岛素受体底物-1  
文章编号:1672-7347(2005)01-0038-03
收稿时间:2004-06-23
修稿时间:2004年6月23日

Effects of long-term estrogen replacement treatment on the blood pressure and expression of IR and IRS-1 in myocardium
LIU Mei-lian,XU Xia,XIE Ping,LU Jin,CHEN Shu-hua,ZENG Wei-min,SONG Hui-ping.Effects of long-term estrogen replacement treatment on the blood pressure and expression of IR and IRS-1 in myocardium[J].Journal of Central South University (Medical Sciences)Journal of Central South University (Medical Sciences),2005,30(1):38-40.
Authors:LIU Mei-lian  XU Xia  XIE Ping  LU Jin  CHEN Shu-hua  ZENG Wei-min  SONG Hui-ping
Institution:Department of Biochemistry, Institute of Biological Science and Technology, Central South University, Changsha 410078, China
Abstract:OBJECTIVE: To determine the effects of long-term estrogen replacement treatment on blood pressure and expressions of insulin receptor (IR) and insulin receptor substrate-1 ( IRS-1) in myocardium. METHODS: Fifty female SD rats were randomly divided into 3 groups. And then sham ( n = 16), ovariectomy (OVX, n = 17), and estrogen replacement treatment group (OVX + E2, n = 17) were established. Systolic blood pressure of tail artery was determined by tail-cuff technique before the operation and on week 12 after the operation. The expressions of IR and IRS-1 were measured by RT-PCR in myocardium of SD rats. RESULTS: Blood pressure (118.75+/-2.77) mmHg] in OVX was significantly higher than that in the sham ( 103.86+/-1.84) mmHg, P < 0.05 ] and OVX + E2 ( 107.83+/-3.24) mmHg, P < 0.05 ] rats. Expression of IRS-1 in OVX group was significantly lower ( 1.2588+/-0.1045)than that in the sham(2.2089+/-0.0988, P <0.05) and OVX + E2 groups ( 1.9100+/-0.1230, P <0.05 ). However, there was no difference on blood pressure and expression of IRS-1 between sham and OVX + E2 groups (P > 0.05 ). The difference of IR expression has no statistical significance among the 3 groups. CONCLUSION: Long-term estrogen replacement treatment might protect cardiovascular system through decreasing the blood pressure and inducing the expression of IRS-1 in myocardium. However, plasma estrogen level doesn't significantly influence the IR expression.
Keywords:long-term estrogen replacement treatment  blood pressure  insulin sensitivity  insulin receptor  insulin receptor substrate-1
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中南大学学报(医学版)》浏览原始摘要信息
点击此处可从《中南大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号